Investment Counsel Inc. Has $314,000 Position in UnitedHealth Group Inc (UNH)

Share on StockTwits

Investment Counsel Inc. lifted its stake in shares of UnitedHealth Group Inc (NYSE:UNH) by 36.1% during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 1,225 shares of the healthcare conglomerate’s stock after buying an additional 325 shares during the period. Investment Counsel Inc.’s holdings in UnitedHealth Group were worth $314,000 at the end of the most recent quarter.

Other large investors also recently made changes to their positions in the company. FMR LLC boosted its position in UnitedHealth Group by 5.1% in the second quarter. FMR LLC now owns 61,622,355 shares of the healthcare conglomerate’s stock worth $15,118,428,000 after purchasing an additional 2,981,233 shares during the last quarter. Vontobel Asset Management Inc. purchased a new position in UnitedHealth Group in the second quarter worth $404,980,000. Bank of Montreal Can purchased a new position in UnitedHealth Group in the second quarter worth $381,555,000. Janus Henderson Group PLC boosted its position in UnitedHealth Group by 61.7% in the second quarter. Janus Henderson Group PLC now owns 3,525,090 shares of the healthcare conglomerate’s stock worth $864,869,000 after purchasing an additional 1,345,083 shares during the last quarter. Finally, Chevy Chase Trust Holdings Inc. purchased a new position in UnitedHealth Group in the second quarter worth $248,898,000. 85.43% of the stock is currently owned by institutional investors.

NYSE:UNH opened at $263.54 on Wednesday. The company has a debt-to-equity ratio of 0.61, a quick ratio of 0.75 and a current ratio of 0.69. UnitedHealth Group Inc has a 52-week low of $208.48 and a 52-week high of $272.81. The firm has a market cap of $251.22 billion, a P/E ratio of 26.17, a P/E/G ratio of 1.50 and a beta of 0.78.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings data on Tuesday, October 16th. The healthcare conglomerate reported $3.41 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.30 by $0.11. UnitedHealth Group had a return on equity of 23.62% and a net margin of 5.71%. The company had revenue of $56.56 billion for the quarter, compared to analyst estimates of $56.34 billion. During the same period in the previous year, the company posted $2.66 EPS. The firm’s revenue for the quarter was up 12.4% compared to the same quarter last year. Research analysts forecast that UnitedHealth Group Inc will post 12.81 earnings per share for the current year.

In related news, CEO Steven H. Nelson sold 8,142 shares of the business’s stock in a transaction on Thursday, September 13th. The stock was sold at an average price of $265.00, for a total transaction of $2,157,630.00. Following the sale, the chief executive officer now directly owns 22,496 shares in the company, valued at approximately $5,961,440. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, CEO Steven H. Nelson sold 26,033 shares of the business’s stock in a transaction on Friday, September 7th. The shares were sold at an average price of $270.65, for a total value of $7,045,831.45. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 69,568 shares of company stock worth $18,539,877. 0.87% of the stock is currently owned by corporate insiders.

Several research analysts have weighed in on the company. Bank of America boosted their price objective on UnitedHealth Group from $315.00 to $320.00 and gave the stock a “buy” rating in a research report on Wednesday, October 17th. Jefferies Financial Group upped their price target on UnitedHealth Group from $270.00 to $311.00 and gave the company a “buy” rating in a research report on Wednesday, October 3rd. ValuEngine raised UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Tuesday, October 2nd. Morgan Stanley upped their price target on UnitedHealth Group from $278.00 to $305.00 and gave the company an “overweight” rating in a research report on Wednesday, September 5th. Finally, Citigroup cut UnitedHealth Group from a “buy” rating to a “neutral” rating and set a $288.00 price target on the stock. in a research report on Monday, September 10th. One research analyst has rated the stock with a hold rating, twenty-two have issued a buy rating and one has assigned a strong buy rating to the stock. The company has an average rating of “Buy” and a consensus target price of $289.41.

ILLEGAL ACTIVITY WARNING: “Investment Counsel Inc. Has $314,000 Position in UnitedHealth Group Inc (UNH)” was first published by Week Herald and is the sole property of of Week Herald. If you are reading this piece on another website, it was illegally stolen and reposted in violation of US & international copyright & trademark laws. The correct version of this piece can be read at https://weekherald.com/2018/11/07/investment-counsel-inc-has-314000-position-in-unitedhealth-group-inc-unh.html.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.

Further Reading: Understanding each part of a balance sheet

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply